Acrotech Biopharma LLC   Report issue

For profit Phase 1 Phase 2
Founded: East Windsor NJ United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04184869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Acrotech Biopharma | Acrotech BioPharmaceuticals, Inc. | Acrotech Biopharma LLC